Gallbladder cancer (GBC): 10-Year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)

Journal of Surgical Oncology

Volumn 98, Issue 7, 2008, Pages 485-489

  Duffy, A ^a   Capanu, M ^a   Abou Alfa, G K ^a   Huitzil, D ^a   Jarnagin, W ^a   Fong, Y ^a   D'Angelica, M ^a   Dematteo, R P ^a   Blumgart, L H ^a   O'Reilly, E M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adjuvant; Chemotherapy; Gallbladder

Indexed keywords

CAPECITABINE; FLUOROURACIL; GEMCITABINE;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER REGISTRY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHOLECYSTECTOMY; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; EXPERIENCE; FEMALE; FOLLOW UP; GALLBLADDER BIOPSY; GALLBLADDER CANCER; HISTOLOGY; HUMAN; INCIDENTAL FINDING; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MONOTHERAPY; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PALLIATIVE THERAPY; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOMA; SEX RATIO; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; CHOLECYSTECTOMY; CHOLECYSTECTOMY, LAPAROSCOPIC; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; GALLBLADDER NEOPLASMS; HEPATECTOMY; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; NEUROENDOCRINE TUMORS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL ANALYSIS;

EID: 56649106675     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21141     Document Type: Article

References (23)

1. SEER database. (Accessed 6/7/07, at http://seer.cancer.gov/.).
2. Donohue JH, Stewart AK, Menck HR: The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995. Cancer 1998;83:2618-2628.
3. Lazcano-Ponce EC, Miquel JF, Munoz N, et al.: Epidemiology and molecular pathology of gallbladder cancer. CA: Cancer J Clin 2001;51:349-364.
4. Leonard GD, O'Reilly EM: Biliary tract cancers: Current concepts and controversies. Expert Opin Pharmacother 2005;6:211-223.
5. Takada T, Amano H, Yasuda H, et al.: Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002;95:1685-1695.
6. Fong Y, Jarnagin W, Blumgart LH: Gallbladder cancer: Comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surgery 2000;232:557-569.
7. Chan SY, Poon RT, Lo CM, et al.: Management of carcinoma of the gallbladder: A single-institution experience in 16 years. J Surg Oncol 2008;97:156-164.
8. Shimizu T, Arima Y, Yokomuro S, et al.: Incidental gallbladder cancer diagnosed during and after laparoscopic cholecystectomy. J Nippon Med School (Nihon Ika Daigaku zasshi) 2006;73:136-140.
9. de Aretxabala X, Roa I, Berrios M, et al.: Chemoradiotherapy in gallbladder cancer. J Surg Oncol 2006;93:699-704.
10. Xiaodong H, Yi X, Chaoji Z, et al.: Overview for the diagnosis and treatment of gallbladder carcinoma. Chin Med Sci J (Chung-kuo i hsueh k'o hsueh tsa chih/Chin Acad Med Sci) 2000;15:115-118.
11. Jarnagin WR, Ruo L, Little SA, et al.: Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies. Cancer 2003;98:1689-1700.
12. Kayahara M, Nagakawa T: Recent trends of gallbladder cancer in Japan: An analysis of 4,770 patients. Cancer 2007;110:572-580.
13. Wang SJ, Fuller CD, Kim JS, et al.: Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 2008;26:2112-2117.
14. Penz M, Kornek GV, Raderer M, et al.: Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 2001;12:183-186.
15. Teufel A, Lehnert T, Stremmel W, et al.: Chemotherapy with gemcitabine in patients with advanced gallbladder carcinoma. Zeitschrift fur Gastroenterologie 2000;38:909-912.
16. Murad AM, Guimaraes RC, Aragao BC, et al.: Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer. Am J Clin Oncol 2003;26: 151-154.
17. Papakostas P, Kouroussis C, Androulakis N, et al.: First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. Eur J Cancer 2001;37:1833-1838.
18. Gallardo JO, Rubio B, Fodor M, et al.: A phase II studyof gemcitabine in gallbladder carcinoma. Ann Oncol 2001;12: 1403-1406.
19. Doval DC, Sekhon JS, Gupta SK, et al.: A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer 2004;90:1516-1520.
20. NCI clinical trials. (Accessed 9/21/07, at http://www.cancer.gov/search/ viewclinicaltrials.aspx?cdrid=455013&version=patient&protocolsearchid= 3678231).
21. Fong Y, Heffernan N, Blumgart LH: Gallbladder carcinoma discovered during laparoscopic cholecystectomy: Aggressive reresection is beneficial. Cancer 1998;83:423-427.
22. Czito BG, Hurwitz HI, Clough RW, et al.: Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: A 23-year experience. Int J Radiat Oncol Biol Phys 2005;62:1030-1034.
23. Kresl JJ, Schild SE, Henning GT, et al.: Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 2002;52:167-175.